LUND.CO acquires ALDR for $18/sh in cash—(+CVR)—an 84% premium to Friday’s close: https://finance.yahoo.com/news/lundbeck-acquire-alder-biopharmaceuticals-company-055552277.html The nominal deal value is $1.95B.